Dihydrotestosterone (DHT)

For research use only. Not for use in humans.

目录号：S4757 别名： androstanolone, stanolone, 5α-DHT 中文名称：双氢睾酮

Dihydrotestosterone (DHT) Chemical Structure

CAS No. 521-18-6

Dihydrotestosterone (DHT, androstanolone, stanolone, 5α-DHT)是一种内源性的雄激素性类固醇和激素，是雄激素受体的激动剂，其亲和力比睾酮高2-3倍，诱导雄激素受体信号的效力比睾酮高3倍。

规格

价格

库存

购买数量

10mM (1mL in DMSO)	RMB 1367.81	现货
25mg	RMB 1286.81	现货
100mg	RMB 3030.86	现货
大包装	有超大折扣

大剂量询单有大折扣!

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的Dihydrotestosterone (DHT)发表文献6篇：

Environ Health Perspect, 2021, 129(4):47010

PubMed: 33851871 ( click the link to review the publication )

Hum Reprod, 2020, 6 pii: deaa077

PubMed: 32372097 ( click the link to review the publication )

Prostate, 2020, 80(9):674-686

PubMed: 32294305 ( click the link to review the publication )

Biochem Biophys Res Commun, 2020, 21;526(1):267-272

PubMed: 32209261 ( click the link to review the publication )

Onco Targets Ther, 2020, 13:9821-9837

PubMed: 33061460 ( click the link to review the publication )

Circulation, 2019, 140(13):1070-1080

PubMed: 31378084 ( click the link to review the publication )

产品安全说明书

Androgen Receptor抑制剂选择性比较

生物活性

产品描述

靶点

Androgen Receptor ^[1]
()

体外研究

在雄激素受体阳性的膀胱癌UMUC3和TCC-SUP细胞中，dihydrotestosterone (DHT)可在mRNA和蛋白水平上增加EGFR和ERBB2的表达。在AR阳性细胞中，DHT还可上调EGFR磷酸化水平及其下游蛋白AKT（pAKT）和ERK1/2(pERK)的磷酸化水平^[1]。

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Activity Description	PMID
CV-1 cell	MVHGeY5kfGmxbjDhd5NigQ>?			NIX2OFhC\2:waYP0bYMh[WO2aY\peJkhMEWFNUCpJIFo[Wmwc4SgbJVu[W5iYX7kdo9o\W5icnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGNXNTFiY3XscEwhTUN3ME2wMlAxPiEQvF2=	MlnMQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwQTh5MUWzOEc,QTh5MUWzOFww[T5?
MDA-MB-453 cell	MmX6SpVv[3Srb36gZZN{[Xl?			MmrWSIl{eGyjY3Xt[Y51KG:oIGuzTH1FUFRiZoLvcUBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDlfJBz\XO\|ZXSgbY4hVUSDLV3CMVQ2OyClZXzsd{BjgSC5aH;s[UBk\WyuIILlZ4VxfG:{IHLpcoRqdmdiYYPzZZktKEurPUCuNFAxOiEQvF2=	M4PvbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF5MEO0NVE4Lz5zN{CzOFEyPzxxYU6=
HepG2 cell	NWG1eG9YTnWwY4Tpc44h[XO\|YYm=			NVzqNGx[SWO2aY\peJkh[WejaX7zeEBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjDlfJBz\XO\|ZXSgbY4hUGWyR{KgZ4VtdHNiYYPz[ZN{\WRiYYOgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHjeIl3[XSrb36sJGlEPTB;MD6wNVgzKM7:TR?=	MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzF2OUi2Okc,OTdzNEm4OlY9N2F-
MDA453 cell	NX7DRmV{TnWwY4Tpc44h[XO\|YYm=			MXPEbZNxdGGlZX3lcpQhd2ZiW{PIYWRJXCCocn;tJIh2dWGwIFHSJIlvKE2GQUS1N{Bk\WyuczygT4k:OC5yMEOg{txO	NFHKRWQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{G4NVE1OSd-MUexPFEyPDF:L3G+
mouse C2C12 cell	MV;GeY5kfGmxbjDhd5NigQ>?			NWT5fYhySWexbnnzeEBi[3Srdnn0fUBifCC{YYSgRXIhfHKjboPm[YN1\WRiaX6gcY92e2ViQ{LDNVIh[2WubIOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiC2cnHud4FkfGm4YYTpc44h[XO\|YYmsJGVEPTB;MD6wNlgh\|ryP	NGXtd2g9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{G4NVE1OSd-MUexPFEyPDF:L3G+
monkey COS7 cell	M3f4XGZ2dmO2aX;uJIF{e2G7			NXvGW4xRSmmwZHnu[{Bi\m[rbnn0fUB1dyCqdX3hckBidmS{b3flckBz\WOncITvdkBmgHC{ZYPz[YQhcW5ibX;ub4V6KEORU{egZ4VtdHNiYomge4hwdGViY3XscEBjcW6maX7nJIF{e2G7LDDLbV0xNjByMEKg{txO	NHvWNYk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOES0NlkyOid-MUi0OFI6OTJ:L3G+
CHO cell	MmLvSpVv[3Srb36gZZN{[Xl?			MXPB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGTHVlUh\XiycnXzd4VlKGmwIFPIU{Bk\WyuczDifUBtfWOrZnXyZZNmKGG\|c3H5MEBGSzVyPUSuOFkh\|ryP	NIPuc2I9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOEOwO\|I6PCd-MUizNFczQTR:L3G+
COS7 cell	NEjQZmtHfW6ldHnvckBie3OjeR?=			NEfJdXpC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJIFv\HKxZ3XuJJJm[2WydH;yJHc4PDGFIH31eIFvfCCneIDy[ZN{\WRiaX6gR29UPyClZXzsd{Bie3Onc4Pl[EBieyCudXPp[oVz[XOnIHHjeIl3cXS7IHHmeIVzKDJ2IHjyd{BjgSC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR\|UxRTBwMEGyJO69VQ>?	M4rzUlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEm0Nlc6Lz5{MkC5OFI4QTxxYU6=
COS7 cell	M1j2SGZ2dmO2aX;uJIF{e2G7			NYHreXR2SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBidmS{b3flckBz\WOncITvdkBVQDd5QTDteZRidnRiZYjwdoV{e2WmIHnuJGNQWzdiY3XscJMh[XO\|ZYPz[YQh[XNibIXjbYZmemG\|ZTDhZ5Rqfmm2eTDh[pRmeiB{NDDodpMh[nlicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkCxOUDPxE1?	NU\m[ZRwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwPVQzPzlpPkKyNFk1Ojd7PD;hQi=>
COS7 cell	NIjKfGpHfW6ldHnvckBie3OjeR?=			M1TubGFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gZY5lem:pZX6gdoVk\XC2b4Kg[ZhxemW\|c3XkJIlvKEORU{egZ4VtdHNiYYPz[ZN{\WRiYYOgcJVkcW[ncnHz[UBi[3Srdnn0fUBi\nSncjCyOEBpenNiYomgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlAxPjJizszN	NI\2T\|k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkC5OFI4QSd-MkKwPVQzPzl:L3G+
LNCaP-hr cell	MVnGeY5kfGmxbjDhd5NigQ>?		M3vxW\|Mh\GG7cx?=	NWLqcW9WSWexbnnzeEBi[3Srdnn0fUBifCCDbnTyc4dmdiC{ZXPldJRweiCWOEe3RUBufXSjboSgbY4hcHWvYX6gUG5E[VBvaIKgZ4VtdHNiYYPz[ZN{\WRiYYOgdJJwe3SjdHWgd5Bm[2moaXOgZY51cWenbjDz[YNz\XSrb36gcYVie3W{ZXSgZYZ1\XJiMzDkZZl{KGK7IHXufplu\S2rbX31co9ie3OjeTygSWM2OD1yLkCxOUDPxE1?	MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF7OUS3O{c,OjNzOUm0O\|c9N2F-
LNCaP-hr cell	NEHzZ\|JHfW6ldHnvckBie3OjeR?=		NYjKWplQOyCmYYnz	MXHB[49vcXO2IHHjeIl3cXS7IHH0JJdqdGRidInw[UBCdmS{b3flckBz\WOncITvdkBqdiCqdX3hckBNVkOjUD3odkBk\WyuczDhd5Nme3OnZDDhd{Bxem:\|dHH0[UB{eGWlaX\pZ{BidnSrZ3XuJJNm[3KndHnvckBu\WG\|dYLl[EBi\nSncjCzJIRigXNiYomg[Y57gW2nLXntcZVvd2G\|c3H5MEBGSzVyPUCuNFA3OiEQvF2=	NHzoZnk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{G5PVQ4Pyd-MkOxPVk1Pzd:L3G+
HEK293 cell	MUPGeY5kfGmxbjDhd5NigQ>?			M1OzcWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gZY5lem:pZX6gdoVk\XC2b4Kg[ZhxemW\|c3XkJIlvKEiHS{K5N{Bk\WyuczDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5zODDuUS=>	M3LSTlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3M{C1Olg5Lz5{NUOwOVY5QDxxYU6=
COS	NFnCcmlHfW6ldHnvckBie3OjeR?=			NF21OY5DcW6maX7nJIFn\mmwaYT5JIFo[Wmwc4SgRY5lem:pZX6gdoVk\XC2b4Kg[ZhxemW\|c3XkJGNQWyClZXzsd{whU2liPTCwMlAxOiEQvF2u	M4TtblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493Nzl6N{G1N\|QoRjl6N{G1N\|Q9N2F-
COS-1	MUXGeY5kfGmxbjDhd5NigQ>?			M1HM[2JqdmSrbnegZYZncW6rdImg[o9zKGi3bXHuJGFv\HKxZ3XuJJJm[2WydH;yJIV5eHKnc4Pl[EBqdiCFT2OtNUBk\WyuczygT4khRSByLkCwN{DPxE1w	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek86QTJ3N{K1K\|46QTJ3N{K1QE9iRg>?
CV-1	M1n3ZmZ2dmO2aX;uJIF{e2G7			NYfw[4hZSWexbnnzeEBi[3Srdnn0fUBi\2GrboP0JGh2dWGwIFHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBEXi1zIHPlcIx{NCCHQ{WwJF0hOC5yMEWg{txONg>?	Mn3ZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwQTl{NUeyOUc,QTl{NUeyOVww[T5?
COS	NFTIbHBHfW6ldHnvckBie3OjeR?=			M3r4cGlvKH[rdILvJIJqdmSrbnegZYZncW6rdImgZZQhcHWvYX6gZY5lem:pZX6gdoVk\XC2b4KgeJJidnOoZXP0[YQhcW62bzDDU3Mh[2WubIOuMEBKSzVyIE2gNE4xODRizszNMi=>	M2DTWlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFyMkOwOlI5Lz5zMEKzNFYzQDxxYU6=
CV-1	NEHmb4hHfW6ldHnvckBie3OjeR?=			M1vFdmlvKH[rdILvJIFod26rc4TpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIHHu[JJw\2WwIILlZ4VxfG:{IIXzbY5oKGOxdILhcpNn\WO2aX;uJIF{e2G7IHnuJGNXNTFiY3XscJMvNCCHQ{WwJF0hOC5yME[g{txONg>?	M1[zZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzFyMkOwOlI5Lz5zMEKzNFYzQDxxYU6=
CV-1	MYDGeY5kfGmxbjDhd5NigQ>?			NV\Kc411SWexbnnzeEBi[3Srdnn0fUB1dyC2aHWgbJVu[W5iYX7kdo9o\W5icnXj[ZB1d3JiKHjBVkkhcW5iQ2[tNUBk\WyuczygSWM2OCB;IECuNFA3KM7:TT6=	MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yODN2ME[yOEc,OTB\|NEC2NlQ9N2F-
CV1	Ml\VSpVv[3Srb36gZZN{[Xl?			M1vBTmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gZY5lem:pZX6gdoVk\XC2b4KgbY4hS1ZzIHPlcIx{KG2nYYP1doVlKGG\|IIP0bY12dGG2aX;uJI9nKGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBi[3Srdnn0fUBjgSClb4TyZY5{\mWldHnvckBie3OjeTygSWM2OCB;IECuNFA2OSEQvF2u	Ml7yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTdyM{SxNVcoRjF5MEO0NVE4RC:jPh?=
CV1	Mo\XSpVv[3Srb36gZZN{[Xl?			NV7HdYJxSmmwZHnu[{Bi\m[rbnn0fUB1dyCqdX3hckBidmS{b3flckBz\WOncITvdkBmgHC{ZYPz[YQhcW5iQ2[xJINmdGy\|LDDLbUA:KDBwMECwNkDPxE1w	NF7Kb5o9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{K1O\|g{QCd-MUeyOVc5Ozh:L3G+
CV1	NXPj[YZbTnWwY4Tpc44h[XO\|YYm=			MWXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBEXjFiY3XscJMtKEWFNUCgQUAxNjByNUGg{txONg>?	MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzJ3N{izPEc,OTd{NUe4N\|g9N2F-
MDA-MB-453	NVjycYd3TnWwY4Tpc44h[XO\|YYm=			Mme2SIl{eGyjY3Xt[Y51KG:oIGuzTH1FUFRiZoLvcUBpfW2jbjDBVkBmgHC{ZYPz[YQhcW5iTVTBMW1DNTR3MzDj[YxteyxiS3mgQUAxNjByMEOg{txONg>?	NWXOeoZ1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe0N\|kyOTJpPkG3OFM6OTF{PD;hQi=>
CV1	MYrGeY5kfGmxbjDhd5NigQ>?			MXTB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBEXjFiY3XscJMh[nlidILhcpNkemmydHnvcoFtKGGldHn2ZZRqd25iYYPzZZktKEWFNUCgQUAxNjByNUeg{txONg>?	NUK5doltRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUe0N\|kyOTJpPkG3OFM6OTF{PD;hQi=>
CV1	NUe2VIVrTnWwY4Tpc44h[XO\|YYm=			MUTB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBEXjFiY3XscJMh[nlidILhcpNkemmydHnvcoFtKGGldHn2ZZRqd25iYYPzZZktKEWFNUCgQUAxNjByNUeg{txONg>?	MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yPzdyM{mzPEc,OTd5MEO5N\|g9N2F-
MDA-MB-453	NG\kS\|NHfW6ldHnvckBie3OjeR?=			NEDMPW5FcXOybHHj[Y1mdnRib3[gX\|NJZUSKVDDmdo9uKGi3bXHuJGFv\HKxZ3XuJJJm[2WydH;yJIlvKGi3bXHuJG1FSS2PQj20OVMh[2WubIOsJGtqKD1iMD6wNFA6KM7:TT6=	M2XjNFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NECwOFk6Lz5zOESwNFQ6QTxxYU6=
CV1	NID0b2hHfW6ldHnvckBie3OjeR?=			NVrlRVBvSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBidmS{b3flckBz\WOncITvdkBqdiCFVkGgZ4VtdHNiYomgeJJidnOlcnnweIlwdmGuIHHjeIl3[XSrb36gZZN{[XluIFXDOVAhRSByLkCwOVch\|ryPLh?=	MVm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQDRyMES5PUc,OTh2MEC0PVk9N2F-
Saos2	NYrtbVA4TnWwY4Tpc44h[XO\|YYm=			M1\nWGFkfGm4aYT5JIF1KGGwZILv[4VvKHKnY3XweI9zKGmwIHj1cYFvKFOjb4OyJINmdGy\|IHHzd4V{e2WmIHHzJGlNPiC{ZYDy[ZN{cW:wLDDJR\|UxKD1iMD6wNFAxPSEQvF2u	NUP2b\|VIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUi0OFI6OTJpPkG4OFQzQTF{PD;hQi=>
CV1	M2K4c2Z2dmO2aX;uJIF{e2G7			M3fR[2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gZY5lem:pZX6gdoVk\XC2b4KgZYZzcWOjbjDndoVmdiCvb37r[ZkhS1ZzIHPlcIx{KGK7IHPveJJidnOoZXP0bY9vKGG\|c3H5MEBGSzVyIE2gNE4xODVzIN88UU4>	M1fkeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF6NESyPVEzLz5zOES0NlkyOjxxYU6=
MDA-kb2	MYLGeY5kfGmxbjDhd5NigQ>?			MmX6RYdwdmm\|dDDhZ5Rqfmm2eTDheEBidmS{b3flckBz\WOncITvdkBqdiCqdX3hckBOTEFva3KyJINmdGy\|IHHzd4V{e2WmIHHzJJN1cW23bHH0bY9vKG:oIHz1Z4ln\XKjc3WgZYN1cX[rdImgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR\|E2OCB;IECuNFAxPSEQvF2u	MYi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTV7MkK0OUc,OTl3OUKyOFU9N2F-
MDA-kb2	NX32VItwTnWwY4Tpc44h[XO\|YYm=			NGj1Z4dC\2:waYP0JIFkfGm4aYT5JIF1KGeudXPvZ49zfGmlb3nkJJJm[2WydH;yJIlvKGi3bXHuJG1FSS2tYkKgZ4VtdHNiYYPz[ZN{\WRiYYOgd5RqdXWuYYTpc44hd2ZibIXjbYZmemG\|ZTDhZ5Rqfmm2eTDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDNVUxKD1iMD6wNFA2KM7:TT6=	NXu3XXRORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMUm1PVIzPDVpPkG5OVkzOjR3PD;hQi=>
MDA-MB-453	NE\5c3RHfW6ldHnvckBie3OjeR?=			M3rDemRqe3CuYXPlcYVvfCCxZjDbN2hedWW2aInseJJq\W6xbH;u[UBnem:vIHHu[JJw\2WwIILlZ4VxfG:{IHnuJIh2dWGwIF3ERU1OSi12NUOgZ4VtdHNuIFnDOVAhRSByLkCwNUDPxE1w	MmixQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4ME[4O\|AoRjF7NkC2PFcxRC:jPh?=
MDA-MB-453	NW\3UGFqTnWwY4Tpc44h[XO\|YYm=			MknWRYdwdmm\|dDDhZ5Rqfmm2eTDheEBidmS{b3flckBz\WOncITvdkBqdiCqdX3hckBOTEFvTVKtOFU{KGOnbHzzJJRz[W6\|ZnXjeIVlKHerdHigUW1VXi2OVVOgZZN{\XO\|ZXSgZZMhcW6mdXP0bY9vKG:oIF3NWHYuVFSUL4Dyc41wfGW{IHzpcotm\CCOVVOg[4Vv\SCkeTDseYNq\mW{YYPlJJRz[W6\|YXP0bZZifGmxbjDhd5NigSxiRVO1NEA:KDBwMECyJO69VS5?	MkC4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOTl4ME[4O\|AoRjF7NkC2PFcxRC:jPh?=
NIH3T3	M1PlXWZ2dmO2aX;uJIF{e2G7			M4jqbWFod26rc4SgZYN1cX[rdImgZZQh[W6mcn;n[Y4hemWlZYD0c5IhVEKGIGS4O\|dCKG23dHHueEBqdiCvb4Xz[UBPUUh\|VEOgZ4VtdHNidILhcpNq\W62bImgeJJidnOoZXP0[YQhf2m2aDDi[ZRiNWejbHHjeI9{cWSjc3WgdoVxd3K2ZYKg[4Vv\SCjc4Pld5Nm\CCjczDj[YxtfWyjcjD0doFve2[xcn3heIlwdiCkeTDSMXNCXCCjc4PhfUwhTUN3MDC9JFAvODBzMkW5JO69VS5?	MU[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8yQTh3NkmyNUc,OTl6NU[5NlE9N2F-
NIH3T3	MnPLSpVv[3Srb36gZZN{[Xl?			NWfvTGFNSWexbnnzeEBi[3Srdnn0fUBifCCjbnTyc4dmdiC{ZXPldJRweiCrbjDtc5V{\SCQSVizWFMh[2WubIOgeJJidnOrZX70cJkhfHKjboPm[YN1\WRid3n0bEBj\XSjLXfhcIFkfG:\|aXThd4UhemWyb4L0[ZIh\2WwZTDhd5Nme3OnZDDhd{Bk\WyudXzhdkB1emGwc3\vdo1ifGmxbjDifUBTNVODVDDhd5NigSxiRVO1NEA:KDBwMECzPVgyKM7:TT6=	NFS3cJc9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zOUi1OlkzOSd-MUm4OVY6OjF:L3G+
COS7	NGXaeIFHfW6ldHnvckBie3OjeR?=			MoHIRYdwdmm\|dDDhZ5Rqfmm2eTDheEBidmS{b3flckBz\WOncITvdkBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJIFnemmlYX6g[5Jm\W5ibX;ub4V6KEORU{egZ4VtdHNiY3:teJJidnOoZXP0[YQhf2m2aDDHZYw1NUSERDDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkCyJO69VS5?	M3fWdVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzF7OE[zNFg{Lz5zOUi2N\|A5OzxxYU6=
Freestyle293F	NVjadZVjTnWwY4Tpc44h[XO\|YYm=		MYCzJIhzew>?	NFK3dmVFcXOybHHj[Y1mdnRib3[gX\|E4NWGucHjhMY1mfGi7bD2zTH0udWmkb3zldo9v\SCocn;tJIh2dWGwIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBJTUt{OUOg[IVzcX[nZDDGdoVmW3S7bHWyPVNHKGOnbHzzJIFnfGW{IEOgbJJ{NCCLQ{WwJF0hOC5yMEKxJO69VS5?	NYfPTldnRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKwPVQzPzlpPkKyNFk1Ojd7PD;hQi=>
Freestyle293F	NETQVYZHfW6ldHnvckBie3OjeR?=		Mo\zN{BpenN?	MkD5SIl{eGyjY3Xt[Y51KG:oIGuxO{1idHCqYT3t[ZRpgWxvM1jdMY1q[m:uZYLvcoUh\nKxbTDoeY1idiCjbnTyc4dmdiC{ZXPldJRweiCWOEe3RUBufXSjboSg[ZhxemW\|c3XkJIlvKEiHS{K5N{Bl\XKrdnXkJGZz\WWVdIns[VI6O0ZiY3XscJMh[W[2ZYKgN{BpenNuIFnDOVAhRSByLkCwNlYh\|ryPLh?=	MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjB7NEK3PUc,OjJyOUSyO\|k9N2F-
HeLa	NI\JUY1HfW6ldHnvckBie3OjeR?=			M3jLTXRz[W6\|YXP0bZZifGmxbjDv[kBpfW2jbjDhcoRzd2enbjDy[YNmeHSxcjD0doFve2[nY4Tl[EBqdiCqdX3hckBJ\UyjIHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhSWO2aY\peJkhRSByLkCwPEDPxE1w	MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjh7N{[xNUc,OjJ6OUe2NVE9N2F-
HeLa	Mli1SpVv[3Srb36gZZN{[Xl?			MmHnVIFzfGmjbDDh[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBJ\UyjIHPlcIx{KGOxLXX4dJJme3OrbnegRXJGKGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCkYYPl[EB1emGwc3HjeIl3[XSrb36gZZN{[XluIFHjeIl3cXS7IE2gNE4xODhizszNMi=>	MlvwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7NUe5OFcoRjJ{OUW3PVQ4RC:jPh?=
Freestyle293F	M{S2NWZ2dmO2aX;uJIF{e2G7			MXLJcohq[mm2aX;uJI9nKHerbHSgeJlx\SCDbnTyc4dmdiC{ZXPldJRweiBqdX7rco94diCxcnnnbY4qKGW6cILld5Nm\CCrbjDGdoVme3S7bHWyPVNHKGOnbHzzMEBKSzVyIE2gNE4xODJzIN88UU4>	NVW0VphKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxPVk1PzdpPkKzNVk6PDd5PD;hQi=>
Freestyle293F	MlLySpVv[3Srb36gZZN{[Xl?			M3WwN2lvcGmkaYTpc44hd2ZiQX7kdo9o\W5icnXj[ZB1d3JiVEi3O2EhdXW2YX70JEh2dmuwb4fuJI9zcWerbjmg[ZhxemW\|c3XkJIlvKE[{ZXXzeJlt\TJ7M1[gZ4VtdHNuIFnDOVAhRSByLkCwNlYh\|ryPLh?=	NXLNeYpjRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxPVk1PzdpPkKzNVk6PDd5PD;hQi=>
COS7	MnjtSpVv[3Srb36gZZN{[Xl?		M3HKclIhcHK\|	MUTEbZNxdGGlZX3lcpQhd2ZiW{PIYUBePWGucHjhMWRJXCCocn;tJI1wfXOnIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBud26tZYmgR29UPyClZXzsd{Bi\nSncjCyJIhzeyCkeTDzZ4lvfGmubHH0bY9vKGOxdX70bY5oKGGwYXz5d4l{NCCLQ{WwJF0hOC5yMEGg{txONg>?	NUjXcndmRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkO1Nlc5OTZpPkKzOVI4QDF4PD;hQi=>
C2C12	MkC0SpVv[3Srb36gZZN{[Xl?		MVW1JIRigXN?	NInCdW5C\2:waYP0JIFkfGm4aYT5JIF1KGGwZILv[4VvKHKnY3XweI9zKGW6cILld5Nm\CCrbjDtc5V{\SCFMlOxNkBk\WyuczDhd5Nme3OnZDDhd{Bwe3Snb3LsZZN1KGSrZn\ldoVvfGmjdHnvckBi\nSncjC1JIRigXNuIFXDOVAhRSByLkCwNFA2KM7:TT6=	NEXRepI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NEmwNFI6OCd-MkS5NFAzQTB:L3G+
C2C12	MWPGeY5kfGmxbjDhd5NigQ>?			MVXB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIHHu[JJw\2WwIILlZ4VxfG:{IHX4dJJme3OnZDDpckBud3W\|ZTDDNmMyOiClZXzsd{BjgSCjbnTyc4dmdi2\|cHXjbYZq[yC{ZYPwc45{\SCnbHXt[Y51NWS{aY\lckBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkCwNFE{KM7:TT6=	NWPXcGx2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC\|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxNlE6PjRpPkK1NVIyQTZ2PD;hQi=>
COS7	M1\WdGZ2dmO2aX;uJIF{e2G7		MkXlNlQhcHK\|	NIDGXZpC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJGFTKGW6cILld5Nm\CCrbjDB[pJq[2GwIHfy[YVvKG2xbnvlfUBEV1N5IHPlcIx{KGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVAhRSByLkCwN{DPxE1w	MmPaQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjh2NUS4OFkoRjJ6NEW0PFQ6RC:jPh?=
Shionogi	M4G5cGZ2dmO2aX;uJIF{e2G7	MUWxNEBxVQ>?		M1T6c2lv\HWldHnvckBw\iCycn;sbYZmemG2aX;uJI9nKG2xdYPlJHNpcW:wb3fpJINmdGy\|IHH0JFExKHCP	NHuwR4U9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9zN{exNVg2PSd-MUe3NVE5PTV:L3G+
MCF7	NYe4PYJ2TnWwY4Tpc44h[XO\|YYm=	NYTqdHdOOzBidV2=	M2rIRlI1KGi{cx?=	MUjBcpRi\2:waYP0JIFkfGm4aYT5JIF1KEGUIHnuJIh2dWGwIF3DSlch[2WubIOgZZN{\XO\|ZXSgZZMhemWmdXP0bY9vKGmwIFHSJIxmfmWuIHH0JFMxKHWPIHHmeIVzKDJ2IHjyd{BjgSCZZYP0[ZJvKGKub4SgZY5idHm\|aYOgdoVt[XSrdnWgeI8h[2:wdILvcC=>	M4TzW\|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{MEG0O\|UyLz5{MkCxOFc2OTxxYU6=

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	Cyclin D1 / Cyclin D2 / Cyclin D3 / Cyclin E2 / Cyclin A1 / AR; PubMed: 26372468 PLoS One HPr-1AR cells were treated with 10 nM DHT or vehicle control for 24–48 hours (h), and immunoblot analysis of cell lysates reveals that cyclin D1 and D2 protein expression decreased substantially with DHT treatment compared to vehicle. p-CDK2 / CDK2 / CDK4 / CDK6 / CDKN1A / p-RB / RB ; PubMed: 26372468 PLoS One HPr-1AR cells were treated with 10 nM DHT or vehicle control for 24–48 hours (h). Immunoblot analysis of cell lysates reveals that CDK4 and CDK6 protein expression decreased and CDKN1A expression increased with DHT treatment compared to vehicle. CDK2 phosphorylation at threonine 160 (T160) decreased nearly 50% with androgen treatment at 24 and 48 hours, albeit not significantly, and total CDK2 protein expression remained unchanged. Relative to total RB expression, the levels of various phosphorylated forms of RB (S780 and S807/811) decreased over time with androgen treatment. p27 / p-p27 ; PubMed: 22139837 J Biol Chem CWR22Rv1 or CWR22R3 cells were stimulated with 10 nm DHT for 6 h, with the addition of MG132 during the last 2 h before harvesting. Proteins were then immunoblotted. AR / PP1 ; PubMed: 26636645 Oncotarget HeLa cells were transfected with Flag-PP1α and HA-AR and then incubated for overnight in androgen-depleted medium without or with androgen (10 nM of DHT) as indicated for blotting.	26372468 22139837 26636645
Immunofluorescence	FOXO1 / p27 ; PubMed: 22139837 J Biol Chem CWR22R3 cells cultured in medium with CDS serum were treated without/with DHT (10 nm) for 4 h. The cells were immunostained for FOXO1 and p27 and examined with a confocal microscope. AKT(S473) / PKCα(S657) ; PubMed: 22139837 J Biol Chem CWR22R3 cells cultured in medium with CDS serum were treated without/with 10 nm DHT (−/+ DHT) for 4 h. The cells were immunostained for AKT or PKCα phosphorylation and examined with a confocal microscope. Bars: 20 μm	22139837

体内研究

DHT可减轻SOD1-G93A小鼠的肌萎缩症状并增加其体重。DHT的处理增加了肌肉中胰岛素样生长因子1的表达，通过逆向轴浆运输发挥其肌肉营养性和神经营养性效果。其处理还减缓了神经肌肉接头处的去神经支配作用、以及减少轴突和运动神经元的丢失。DHT处理的SOD1-G93A小鼠改善了运动行为，生命期限也有所延长^[2]。

细胞实验： ^[1]	- 合并 Cell lines: 膀胱癌细胞 Concentrations: 1 nM Incubation Time: 24 h Method: 对铺于24孔板的、达到50%-60%融合率的细胞进行MMTV-luc报告质粒和PRL-TK-luc质粒共转染实验。转染完6小时后，将培养基替换为含活性炭处理胎牛血清的培养基，加入或不加入配体（DHT、HF或同时加入），处理24小时。收集细胞、溶解、进行荧光素酶活性检测。 (Only for Reference)
动物实验： ^[2]	- 合并 Animal Models: SOD1-G93A mutant mice with the congenic C57BL/6J background Dosages: 5 mg Administration: silastic implant (Only for Reference)

参考文献

溶解度 (25°C)

体外	DMSO	58 mg/mL (199.69 mM)
	Ethanol	58 mg/mL (199.69 mM)
	Water	Insoluble

* 溶解度检测是由Selleck技术部门检测的，可能会和文献中提供的溶解度有所差异，这是由于生产工艺和批次不同产生的正常现象。请按照顺序依次加入各个纯溶剂。

化学数据 Download Dihydrotestosterone (DHT) SDF

分子量	290.44
化学式	C₁₉H₃₀O₂
CAS号	521-18-6
储存条件	3年-20°C 粉状 2年-80°C 溶于溶剂
别名	androstanolone, stanolone, 5α-DHT

动物体内配方计算器 (澄清溶液)

第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量）

给药剂量

mg/kg

动物平均体重

每只动物给药体积

动物数量

只

第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系Selleck为您提供正确的澄清溶液配方）

% DMSO+ % + % Tween 80+ % ddH₂O

计算重置

计算结果:

工作液浓度： mg/ml；

DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，注：如该浓度超过该批次药物DMSO溶解度，请先联系Selleck）；

体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL ddH₂O，混匀澄清。

注意：1. 首先保证母液是澄清的；
2. 一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。

计算器

摩尔浓度计算器

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系，公式为:

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

质量

浓度

体积

分子量
=

×

×

*在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。

稀释计算器

用本工具协助配置特定浓度的溶液，使用的计算公式为：

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为: C1V1 = C2V2 ( 输入输出 )

C1

V1

C2

V2
×

=

×

在配置溶液时，请务必参考Selleck产品标签上、MSDS / COA（可在Selleck的产品页面获得）批次特异的分子量使用本工具。.

连续稀释计算器方程

连续稀释
初始浓度:
稀释倍数:

计算结果

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

分子量计算器

通过输入化合物的化学式来计算其分子量：

注：化学分子式大小写敏感。C10H16N2O2 c10h16n2o2

摩尔浓度计算器

质量	浓度	体积	分子量
=	×	×
计算

临床试验信息 (data from https://clinicaltrials.gov, updated on 2021-05-17)

NCT Number	Recruitment	interventions	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT01724619	Terminated	Drug: [F-18] fluorinated dihydrotestosterone (FDHT)	Prostate Cancer	Wake Forest University Health Sciences	November 2012	Early Phase 1
NCT00490022	Completed	Drug: Dihydrotestosterone (DHT) gel (0.7%)\|Drug: Placebo gel	Healthy	University of Washington\|National Institute on Aging (NIA)\|ASCEND Therapeutics	June 2007	Phase 1\|Phase 2
NCT00062790	Completed	Drug: Dutasteride	Prostatic Hyperplasia	GlaxoSmithKline	October 2003	Phase 4

技术支持

在订购、运输、储存和使用我们的产品的任何阶段，您遇到的任何问题，均可以通过拨打我们的热线电话400-668-6834，或者技术支持邮箱tech@selleck.cn，直接联系到我们。我们会在24小时内尽快联系您。

操作手册

如果有其他问题，请给我们留言。

研究领域

产品类型

定制您的化合物库

Dihydrotestosterone (DHT)

客户使用Selleck生产的Dihydrotestosterone (DHT)发表文献6篇：

产品安全说明书

Androgen Receptor抑制剂选择性比较

生物活性

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

参考文献

溶解度 (25°C)

化学数据 Download Dihydrotestosterone (DHT) SDF

动物体内配方计算器 (澄清溶液)

计算器

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)

摩尔浓度计算公式

稀释计算器

开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

连续稀释计算器方程

连续稀释

计算结果

分子量计算器

总分子量：g/mol

摩尔浓度计算器

临床试验信息 (data from https://clinicaltrials.gov, updated on 2021-05-17)

技术支持

Androgen Receptor Signaling Pathway Map

相关Androgen Receptor产品